共 50 条
- [32] Evaluation of Msh2, Mlh1, Brca1 and Fhit protein expression in T1 N0 M0 breast cancer BREAST, 2005, 14 : S15 - S16
- [34] Surgical-pathologic factors affect long-term outcomes in stage IB (pT2 N0 M0) non-small cell lung cancer: A heterogeneous disease JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2009, 138 (02): : 426 - 433
- [35] THE ROLE OF ADJUVANT THERAPY AFTER RESECTION OF T1 N1 M0 AND T2 N1 M0 NON-SMALL CELL LUNG-CANCER JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 1986, 91 (03): : 344 - 349
- [36] Female breast cancers (T1-2, N0, M0, HR+, HER2-) with an intermediate genetic-based recurrence risk: a real-world estimate in Italy TUMORI JOURNAL, 2019, 105 (06): : 483 - 487
- [39] The critical impact of tumor size in predicting cancer special survival for T3aM0M0 renal cell carcinoma: A proposal of an alternative T3aN0M0 stage CANCER MEDICINE, 2021, 10 (02): : 605 - 614
- [40] Intentional limited resection for selected patients with T1 N0 M0 non-small-cell lung cancer: A single-institution study JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 1997, 114 (03): : 347 - 353